BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29868820)

  • 1. Predicting Cancer Drug Response using a Recommender System.
    Suphavilai C; Bertrand D; Nagarajan N
    Bioinformatics; 2018 Nov; 34(22):3907-3914. PubMed ID: 29868820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting heterogeneity in clone-specific therapeutic vulnerabilities using single-cell transcriptomic signatures.
    Suphavilai C; Chia S; Sharma A; Tu L; Da Silva RP; Mongia A; DasGupta R; Nagarajan N
    Genome Med; 2021 Dec; 13(1):189. PubMed ID: 34915921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting anti-cancer drug response by finding optimal subset of drugs.
    Yassaee Meybodi F; Eslahchi C
    Bioinformatics; 2021 Dec; 37(23):4509-4516. PubMed ID: 34170297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auto-HMM-LMF: feature selection based method for prediction of drug response via autoencoder and hidden Markov model.
    Emdadi A; Eslahchi C
    BMC Bioinformatics; 2021 Jan; 22(1):33. PubMed ID: 33509079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
    Wang L; Li X; Zhang L; Gao Q
    BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GDSCTools for mining pharmacogenomic interactions in cancer.
    Cokelaer T; Chen E; Iorio F; Menden MP; Lightfoot H; Saez-Rodriguez J; Garnett MJ
    Bioinformatics; 2018 Apr; 34(7):1226-1228. PubMed ID: 29186349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
    Wang Y; Yang Y; Chen S; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions.
    Peng W; Liu H; Dai W; Yu N; Wang J
    Bioinformatics; 2022 Sep; 38(19):4546-4553. PubMed ID: 35997568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DSPLMF: A Method for Cancer Drug Sensitivity Prediction Using a Novel Regularization Approach in Logistic Matrix Factorization.
    Emdadi A; Eslahchi C
    Front Genet; 2020; 11():75. PubMed ID: 32174963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression.
    Ammad-Ud-Din M; Khan SA; Wennerberg K; Aittokallio T
    Bioinformatics; 2017 Jul; 33(14):i359-i368. PubMed ID: 28881998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies.
    Nikolova O; Moser R; Kemp C; Gönen M; Margolin AA
    Bioinformatics; 2017 May; 33(9):1362-1369. PubMed ID: 28082455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical drug response prediction from preclinical cancer cell lines by logistic matrix factorization approach.
    Emdadi A; Eslahchi C
    J Bioinform Comput Biol; 2022 Apr; 20(2):2150035. PubMed ID: 34923927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorization.
    Ammad-Ud-Din M; Khan SA; Malani D; Murumägi A; Kallioniemi O; Aittokallio T; Kaski S
    Bioinformatics; 2016 Sep; 32(17):i455-i463. PubMed ID: 27587662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kernelized rank learning for personalized drug recommendation.
    He X; Folkman L; Borgwardt K
    Bioinformatics; 2018 Aug; 34(16):2808-2816. PubMed ID: 29528376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PharmacoGx: an R package for analysis of large pharmacogenomic datasets.
    Smirnov P; Safikhani Z; El-Hachem N; Wang D; She A; Olsen C; Freeman M; Selby H; Gendoo DM; Grossmann P; Beck AH; Aerts HJ; Lupien M; Goldenberg A; Haibe-Kains B
    Bioinformatics; 2016 Apr; 32(8):1244-6. PubMed ID: 26656004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AITL: Adversarial Inductive Transfer Learning with input and output space adaptation for pharmacogenomics.
    Sharifi-Noghabi H; Peng S; Zolotareva O; Collins CC; Ester M
    Bioinformatics; 2020 Jul; 36(Suppl_1):i380-i388. PubMed ID: 32657371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipartite graph-based approach for clustering of cell lines by gene expression-drug response associations.
    Chi C; Ye Y; Chen B; Huang H
    Bioinformatics; 2021 Sep; 37(17):2617-2626. PubMed ID: 33682877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach for drug response prediction in cancer cell lines via network representation learning.
    Yang J; Li A; Li Y; Guo X; Wang M
    Bioinformatics; 2019 May; 35(9):1527-1535. PubMed ID: 30304378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep-Resp-Forest: A deep forest model to predict anti-cancer drug response.
    Su R; Liu X; Wei L; Zou Q
    Methods; 2019 Aug; 166():91-102. PubMed ID: 30772464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel heterogeneous network-based method for drug response prediction in cancer cell lines.
    Zhang F; Wang M; Xi J; Yang J; Li A
    Sci Rep; 2018 Feb; 8(1):3355. PubMed ID: 29463808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.